Centro de Investigación en Red en Enfermedades Cardiovasculares-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2022

  1. Early clinical outcomes after transaxillary versus transfemoral TAVI. Data from the Spanish TAVI registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 479-487

  2. Plaque modification in calcified chronic total occlusions: the PLACCTON study

    Revista Espanola de Cardiologia, Vol. 75, Núm. 3, pp. 213-222

  3. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

2021

  1. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy

    European Heart Journal, Vol. 42, Núm. 32, pp. 3063-3073

  2. Association of Left Ventricular Systolic Dysfunction among Carriers of Truncating Variants in Filamin C with Frequent Ventricular Arrhythmia and End-stage Heart Failure

    JAMA Cardiology, Vol. 6, Núm. 8, pp. 891-901

  3. Impact of lifestyle interventions targeting physical exercise and caloric intake on cirrhosis regression in rats

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 321, Núm. 6, pp. G603-G616

  4. Mental health impact of the first wave of COVID-19 pandemic on Spanish healthcare workers: A large cross-sectional survey

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 2, pp. 90-105

  5. P38γ and p38δ regulate postnatal cardiac metabolism through glycogen synthase 1

    PLoS Biology, Vol. 19, Núm. 11

2020

  1. Metabolic adaptations in spontaneously immortalized PGC-1α knock-out mouse embryonic fibroblasts increase their oncogenic potential

    Redox Biology, Vol. 29